Homotypic and heterotypic neutralization determinants of bluetongue vi
rus serotype 17 (BTV-17) were investigated with a panel of five neutra
lizing monoclonal antibodies (MAbs). One MAb (MAb 034) was originally
raised to BTV serotype 10 (BTV-10) but also neutralizes BTV-17 (P. V.
Rossitto, and N. J. MacLachlan, 1992, J. Gen. Virol. 73, 1947-1952). C
ompetitive binding studies indicate that the MAbs recognize at least t
wo epitopes on the neutralizing outer capsid protein VP2 of BTV-17. Th
e MAbs were used to select neutralization-resistant variant [escape mu
tant (EM)] viruses and to determine the phenotypic characteristics of
these EM viruses by immunoprecipitation and neutralization assays. Seq
uencing of the L2 gene, which encodes VP2, identified mutations respon
sible for the altered phenotypic properties exhibited by each EM virus
. Four amino acids in three regions of VP2 are critical to the express
ion of the epitopes recognized by the panel of neutralizing MAbs. Amin
o acid 199 affects the binding of MAbs 17.82, 17.83, and 17.813; amino
acid 213 affects the binding of MAb 17.85; and amino acids 327 and 58
2 synergistically affect the binding of MAb 034. Similarly, amino acid
s 327 and 402 synergistically affect the binding of MAb 034 to BTV-10
(C. D. DeMaula, H. W. Heidner, P. V. Rossitto, C. M. Pierce, and N. J.
MacLachlan, 1993, Virology 195, 292-296), suggesting that the neutral
izing epitope common to BTV-10 and BTV-17 has a similar location in VP
2 of these two antigenically distinct viruses. (C) 1995 Academic Press
, Inc.